CMTM4 shows evidenced risk of intrauterine growth restriction due to involvement with endothelial vascularization44, potentially suggesting that CMTM4 has a more direct effect in utero, which mediates its associations with body fat percentage and hypertension. This evidence concerns the gene CMTM4 and hypertensive disorder.